Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 28 |
NetGPI | no | yes: 0, no: 28 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9B696
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0030497 | fatty acid elongation | 6 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0008667 | 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase activity | 5 | 1 |
GO:0016491 | oxidoreductase activity | 2 | 3 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 1 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 1 |
GO:0004312 | fatty acid synthase activity | 5 | 2 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 5 | 2 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 2 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016746 | acyltransferase activity | 3 | 2 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 343 | 347 | PF00656 | 0.609 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.321 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.260 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.530 |
DEG_SPOP_SBC_1 | 188 | 192 | PF00917 | 0.374 |
DOC_CDC14_PxL_1 | 392 | 400 | PF14671 | 0.269 |
DOC_CYCLIN_RxL_1 | 167 | 177 | PF00134 | 0.508 |
DOC_MAPK_FxFP_2 | 393 | 396 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 153 | 162 | PF00069 | 0.446 |
DOC_MAPK_MEF2A_6 | 359 | 367 | PF00069 | 0.626 |
DOC_PP1_RVXF_1 | 105 | 111 | PF00149 | 0.416 |
DOC_PP1_RVXF_1 | 168 | 175 | PF00149 | 0.500 |
DOC_PP2B_LxvP_1 | 215 | 218 | PF13499 | 0.458 |
DOC_PP4_FxxP_1 | 243 | 246 | PF00568 | 0.478 |
DOC_PP4_FxxP_1 | 393 | 396 | PF00568 | 0.368 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.321 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.428 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.416 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.400 |
DOC_USP7_UBL2_3 | 121 | 125 | PF12436 | 0.526 |
DOC_USP7_UBL2_3 | 327 | 331 | PF12436 | 0.712 |
DOC_USP7_UBL2_3 | 337 | 341 | PF12436 | 0.730 |
DOC_WW_Pin1_4 | 329 | 334 | PF00397 | 0.712 |
DOC_WW_Pin1_4 | 351 | 356 | PF00397 | 0.723 |
DOC_WW_Pin1_4 | 445 | 450 | PF00397 | 0.354 |
DOC_WW_Pin1_4 | 461 | 466 | PF00397 | 0.381 |
LIG_14-3-3_CanoR_1 | 103 | 110 | PF00244 | 0.467 |
LIG_14-3-3_CanoR_1 | 193 | 199 | PF00244 | 0.588 |
LIG_14-3-3_CanoR_1 | 317 | 322 | PF00244 | 0.547 |
LIG_Actin_WH2_2 | 168 | 184 | PF00022 | 0.544 |
LIG_BRCT_BRCA1_1 | 396 | 400 | PF00533 | 0.442 |
LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.335 |
LIG_BRCT_BRCA1_2 | 396 | 402 | PF00533 | 0.456 |
LIG_deltaCOP1_diTrp_1 | 291 | 297 | PF00928 | 0.642 |
LIG_eIF4E_1 | 210 | 216 | PF01652 | 0.416 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.524 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.464 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.543 |
LIG_FHA_1 | 310 | 316 | PF00498 | 0.448 |
LIG_FHA_1 | 374 | 380 | PF00498 | 0.515 |
LIG_FHA_1 | 417 | 423 | PF00498 | 0.371 |
LIG_FHA_1 | 462 | 468 | PF00498 | 0.400 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.553 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.508 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.425 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.389 |
LIG_FHA_2 | 341 | 347 | PF00498 | 0.627 |
LIG_FHA_2 | 401 | 407 | PF00498 | 0.338 |
LIG_FHA_2 | 448 | 454 | PF00498 | 0.333 |
LIG_LIR_Apic_2 | 242 | 246 | PF02991 | 0.478 |
LIG_LIR_Apic_2 | 390 | 396 | PF02991 | 0.435 |
LIG_LIR_Gen_1 | 291 | 301 | PF02991 | 0.538 |
LIG_LIR_Gen_1 | 93 | 102 | PF02991 | 0.569 |
LIG_LIR_Nem_3 | 291 | 297 | PF02991 | 0.564 |
LIG_LIR_Nem_3 | 377 | 383 | PF02991 | 0.540 |
LIG_LIR_Nem_3 | 390 | 395 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 93 | 99 | PF02991 | 0.495 |
LIG_LYPXL_yS_3 | 395 | 398 | PF13949 | 0.264 |
LIG_PCNA_yPIPBox_3 | 313 | 325 | PF02747 | 0.413 |
LIG_Pex14_1 | 387 | 391 | PF04695 | 0.241 |
LIG_Pex14_2 | 400 | 404 | PF04695 | 0.331 |
LIG_RPA_C_Fungi | 48 | 60 | PF08784 | 0.396 |
LIG_SH2_GRB2like | 27 | 30 | PF00017 | 0.268 |
LIG_SH2_SRC | 27 | 30 | PF00017 | 0.268 |
LIG_SH2_STAP1 | 85 | 89 | PF00017 | 0.280 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 288 | 291 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 378 | 381 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 391 | 394 | PF00017 | 0.280 |
LIG_SH2_STAT5 | 427 | 430 | PF00017 | 0.419 |
LIG_SH3_3 | 280 | 286 | PF00018 | 0.531 |
LIG_SH3_3 | 332 | 338 | PF00018 | 0.539 |
LIG_SH3_4 | 337 | 344 | PF00018 | 0.485 |
LIG_SUMO_SIM_anti_2 | 40 | 45 | PF11976 | 0.188 |
LIG_SUMO_SIM_par_1 | 132 | 139 | PF11976 | 0.250 |
LIG_SUMO_SIM_par_1 | 40 | 45 | PF11976 | 0.199 |
LIG_TYR_ITIM | 298 | 303 | PF00017 | 0.304 |
LIG_UBA3_1 | 321 | 327 | PF00899 | 0.308 |
MOD_CDK_SPxxK_3 | 461 | 468 | PF00069 | 0.301 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.379 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.250 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.309 |
MOD_CK1_1 | 239 | 245 | PF00069 | 0.326 |
MOD_CK1_1 | 407 | 413 | PF00069 | 0.456 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.174 |
MOD_CK2_1 | 400 | 406 | PF00069 | 0.380 |
MOD_CK2_1 | 447 | 453 | PF00069 | 0.433 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.273 |
MOD_GlcNHglycan | 346 | 349 | PF01048 | 0.706 |
MOD_GlcNHglycan | 406 | 409 | PF01048 | 0.384 |
MOD_GlcNHglycan | 429 | 432 | PF01048 | 0.443 |
MOD_GlcNHglycan | 436 | 439 | PF01048 | 0.446 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.311 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.210 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.386 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.282 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.308 |
MOD_GSK3_1 | 325 | 332 | PF00069 | 0.591 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.565 |
MOD_GSK3_1 | 400 | 407 | PF00069 | 0.417 |
MOD_N-GLC_1 | 349 | 354 | PF02516 | 0.703 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.340 |
MOD_NEK2_1 | 309 | 314 | PF00069 | 0.514 |
MOD_NEK2_1 | 400 | 405 | PF00069 | 0.480 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.330 |
MOD_NEK2_2 | 124 | 129 | PF00069 | 0.241 |
MOD_NEK2_2 | 408 | 413 | PF00069 | 0.421 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.321 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.343 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.334 |
MOD_Plk_1 | 224 | 230 | PF00069 | 0.378 |
MOD_Plk_1 | 290 | 296 | PF00069 | 0.426 |
MOD_Plk_4 | 11 | 17 | PF00069 | 0.348 |
MOD_Plk_4 | 239 | 245 | PF00069 | 0.414 |
MOD_Plk_4 | 317 | 323 | PF00069 | 0.380 |
MOD_Plk_4 | 374 | 380 | PF00069 | 0.484 |
MOD_Plk_4 | 394 | 400 | PF00069 | 0.284 |
MOD_ProDKin_1 | 329 | 335 | PF00069 | 0.657 |
MOD_ProDKin_1 | 351 | 357 | PF00069 | 0.667 |
MOD_ProDKin_1 | 445 | 451 | PF00069 | 0.428 |
MOD_ProDKin_1 | 461 | 467 | PF00069 | 0.474 |
MOD_SUMO_rev_2 | 177 | 183 | PF00179 | 0.417 |
MOD_SUMO_rev_2 | 273 | 283 | PF00179 | 0.661 |
TRG_DiLeu_BaLyEn_6 | 104 | 109 | PF01217 | 0.310 |
TRG_DiLeu_BaLyEn_6 | 215 | 220 | PF01217 | 0.263 |
TRG_DiLeu_BaLyEn_6 | 310 | 315 | PF01217 | 0.440 |
TRG_ENDOCYTIC_2 | 22 | 25 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 252 | 255 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.509 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.297 |
TRG_ENDOCYTIC_2 | 380 | 383 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 395 | 398 | PF00928 | 0.280 |
TRG_Pf-PMV_PEXEL_1 | 259 | 263 | PF00026 | 0.567 |
TRG_Pf-PMV_PEXEL_1 | 313 | 318 | PF00026 | 0.466 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZ81 | Leptomonas seymouri | 25% | 87% |
A0A0N1I1M5 | Leptomonas seymouri | 63% | 98% |
A0A0S4IZG2 | Bodo saltans | 25% | 100% |
A0A0S4J1I6 | Bodo saltans | 24% | 100% |
A0A0S4J9U3 | Bodo saltans | 28% | 100% |
A0A1X0P5Q9 | Trypanosomatidae | 25% | 100% |
A0A1X0P5W3 | Trypanosomatidae | 44% | 100% |
A0A3Q8IM89 | Leishmania donovani | 26% | 100% |
A0A3R7K8J6 | Trypanosoma rangeli | 25% | 100% |
A0A3R7N7S2 | Trypanosoma rangeli | 43% | 100% |
A0A3S5H7D5 | Leishmania donovani | 24% | 100% |
A0A3S7X986 | Leishmania donovani | 91% | 100% |
A4HDP2 | Leishmania braziliensis | 24% | 100% |
A4HMN7 | Leishmania braziliensis | 25% | 100% |
A4HMN9 | Leishmania braziliensis | 83% | 100% |
C9ZWC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 97% |
C9ZZF1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AF39 | Leishmania major | 26% | 100% |
E9AF41 | Leishmania major | 89% | 100% |
E9AH88 | Leishmania infantum | 23% | 97% |
E9AHV6 | Leishmania infantum | 27% | 100% |
E9AHV8 | Leishmania infantum | 91% | 100% |
E9AX26 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 99% |
E9B694 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
Q4QAF0 | Leishmania major | 25% | 100% |
V5BJC7 | Trypanosoma cruzi | 27% | 100% |
V5BNY6 | Trypanosoma cruzi | 44% | 100% |